Literature DB >> 33772657

The Difference Between High Density Lipoprotein Subfractions and Subspecies: an Evolving Model in Cardiovascular Disease and Diabetes.

W Sean Davidson1, Allison L Cooke2, Debi K Swertfeger3, Amy S Shah4.   

Abstract

PURPOSE OF REVIEW: The term high density lipoproteins (HDL) refers to an eclectic collection of subparticles that play diverse roles in physiology. Here, we define the term "HDL subspecies" and review recent work on their molecular characterization and relation to disease, focusing on cardiovascular disease and diabetes. RECENT
FINDINGS: The HDL family contains over 200 proteins and nearly 200 lipids that partition into different particles in plasma. Simple subfractionation of HDL based on a particular physicochemical property has not risen to the challenge of revealing the roles of specific particles in disease. However, by targeting minor protein or lipid components, a handful of compositionally defined HDL subspecies have been described and characterized. By combining targeted particle isolation techniques with the power of large human studies, progress is being made in understanding HDL subspecies functions and implications for disease. However, much work remains before these advancements can be translated into disease mitigation strategies.

Entities:  

Keywords:  Cardiovascular disease; High density lipoproteins; Lipoprotein; Lipoprotein subspecies; Pre-beta HDL; Subfractions; Subspecies; Trypanosome lytic factor; Type 2 diabetes

Mesh:

Substances:

Year:  2021        PMID: 33772657      PMCID: PMC8258923          DOI: 10.1007/s11883-021-00925-4

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  59 in total

1.  Relation of increased prebeta-1 high-density lipoprotein levels to risk of coronary heart disease.

Authors:  Lin T Guey; Clive R Pullinger; Brian Y Ishida; Patricia M O'Connor; Christian Zellner; Omar L Francone; Jason M Laramie; Josefina M Naya-Vigne; Ketevan A Siradze; Prakash Deedwania; Rita F Redberg; Philip H Frost; Albert B Seymour; John P Kane; Mary J Malloy
Journal:  Am J Cardiol       Date:  2011-08-01       Impact factor: 2.778

2.  Emerging roles of HDL in immune function.

Authors:  Kate T Creasy; John P Kane; Mary J Malloy
Journal:  Curr Opin Lipidol       Date:  2018-12       Impact factor: 4.776

3.  Distinct Proteomic Signatures in 16 HDL (High-Density Lipoprotein) Subspecies.

Authors:  Jeremy D Furtado; Rain Yamamoto; John T Melchior; Allison B Andraski; Maria Gamez-Guerrero; Patrick Mulcahy; Zeling He; Tianxi Cai; W Sean Davidson; Frank M Sacks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-12       Impact factor: 8.311

4.  A new sandwich enzyme immunoassay for measurement of plasma pre-beta1-HDL levels.

Authors:  O Miyazaki; J Kobayashi; I Fukamachi; T Miida; H Bujo; Y Saito
Journal:  J Lipid Res       Date:  2000-12       Impact factor: 5.922

Review 5.  The trypanolytic factor of human serum: many ways to enter the parasite, a single way to kill.

Authors:  Benoit Vanhollebeke; Etienne Pays
Journal:  Mol Microbiol       Date:  2010-04-01       Impact factor: 3.501

Review 6.  The apoM-S1P axis in hepatic diseases.

Authors:  Zhiyang Chen; Min Hu
Journal:  Clin Chim Acta       Date:  2020-10-21       Impact factor: 3.786

7.  Trypanosome Lytic Factor-1 Initiates Oxidation-stimulated Osmotic Lysis of Trypanosoma brucei brucei.

Authors:  Amy Styer Greene; Stephen L Hajduk
Journal:  J Biol Chem       Date:  2015-12-08       Impact factor: 5.157

8.  Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress.

Authors:  Anatol Kontush; Sandrine Chantepie; M John Chapman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-08-14       Impact factor: 8.311

9.  High-Density Lipoprotein Particles, Cell-Cholesterol Efflux, and Coronary Heart Disease Risk.

Authors:  Bela F Asztalos; Katalin V Horvath; Ernst J Schaefer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

10.  Loss-of-function mutations in APOC3, triglycerides, and coronary disease.

Authors:  Jacy Crosby; Gina M Peloso; Paul L Auer; David R Crosslin; Nathan O Stitziel; Leslie A Lange; Yingchang Lu; Zheng-zheng Tang; He Zhang; George Hindy; Nicholas Masca; Kathleen Stirrups; Stavroula Kanoni; Ron Do; Goo Jun; Youna Hu; Hyun Min Kang; Chenyi Xue; Anuj Goel; Martin Farrall; Stefano Duga; Pier Angelica Merlini; Rosanna Asselta; Domenico Girelli; Oliviero Olivieri; Nicola Martinelli; Wu Yin; Dermot Reilly; Elizabeth Speliotes; Caroline S Fox; Kristian Hveem; Oddgeir L Holmen; Majid Nikpay; Deborah N Farlow; Themistocles L Assimes; Nora Franceschini; Jennifer Robinson; Kari E North; Lisa W Martin; Mark DePristo; Namrata Gupta; Stefan A Escher; Jan-Håkan Jansson; Natalie Van Zuydam; Colin N A Palmer; Nicholas Wareham; Werner Koch; Thomas Meitinger; Annette Peters; Wolfgang Lieb; Raimund Erbel; Inke R Konig; Jochen Kruppa; Franziska Degenhardt; Omri Gottesman; Erwin P Bottinger; Christopher J O'Donnell; Bruce M Psaty; Christie M Ballantyne; Goncalo Abecasis; Jose M Ordovas; Olle Melander; Hugh Watkins; Marju Orho-Melander; Diego Ardissino; Ruth J F Loos; Ruth McPherson; Cristen J Willer; Jeanette Erdmann; Alistair S Hall; Nilesh J Samani; Panos Deloukas; Heribert Schunkert; James G Wilson; Charles Kooperberg; Stephen S Rich; Russell P Tracy; Dan-Yu Lin; David Altshuler; Stacey Gabriel; Deborah A Nickerson; Gail P Jarvik; L Adrienne Cupples; Alex P Reiner; Eric Boerwinkle; Sekar Kathiresan
Journal:  N Engl J Med       Date:  2014-06-18       Impact factor: 91.245

View more
  7 in total

Review 1.  The HDL Proteome Watch: Compilation of studies leads to new insights on HDL function.

Authors:  W Sean Davidson; Amy S Shah; Hannah Sexmith; Scott M Gordon
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2021-11-18       Impact factor: 4.698

2.  Association Between Gestational Diabetes Mellitus and the Risks of Type-Specific Cardiovascular Diseases.

Authors:  Yuanyuan Mao; Wenbin Hu; Bin Xia; Li Liu; Xia Han; Qin Liu
Journal:  Front Public Health       Date:  2022-07-05

3.  Measures of high-density lipoprotein function in men and women with severe aortic stenosis.

Authors:  Anouar Hafiane; Elda Favari; Anna E Bortnick
Journal:  Lipids Health Dis       Date:  2022-05-28       Impact factor: 4.315

4.  Assessing HDL Metabolism in Subjects with Elevated Levels of HDL Cholesterol and Coronary Artery Disease.

Authors:  William Hancock-Cerutti; John S Millar; Silvia Valentini; Jason Liu; Jeffrey T Billheimer; Daniel J Rader; Marina Cuchel
Journal:  Molecules       Date:  2021-11-14       Impact factor: 4.411

Review 5.  Dietary fat and carbohydrate affect the metabolism of protein-based high-density lipoprotein subspecies.

Authors:  Frank M Sacks; Allison B Andraski
Journal:  Curr Opin Lipidol       Date:  2022-02-01       Impact factor: 4.776

Review 6.  HDL functionality in type 1 and type 2 diabetes: new insights.

Authors:  M John Chapman
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2022-04-01       Impact factor: 3.243

Review 7.  The Role of High-Density Lipoprotein Cholesterol in 2022.

Authors:  Cesare R Sirtori; Alberto Corsini; Massimiliano Ruscica
Journal:  Curr Atheroscler Rep       Date:  2022-03-10       Impact factor: 5.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.